My Account
About Us
Contact us
الواجهة العربية
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »

Common Anti-Inflammatory Drugs Can Prevent Esophageal Tumors

Common Anti-Inflammatory Drugs Can Prevent Esophageal Tumors

(epharmanews) – Common anti-inflammatory drugs, such as non-steroidal anti-inflammatory drugs (NSAID) and Tolfenamic acid (TA), can reduce esophageal tumors, according to a new study conducted researchers at MD Anderson Cancer Center Orlando.

The study was led by Pius Maliakal, PhD and Riyaz Basha, PhD, researchers at MD Anderson Orlando’s Cancer Research Institute. They found that Tolfenamic acid prevented the growth of new esophageal tumors and reduced their size in a rat model.

Tolfenamic acid has been found to decrease certain proteins that are critical for cancer cell growth and the progression of esophageal tumors.

There are many types of esophageal tumors, the most common of which is squamous cell carcinoma which is the result of heavy smoking and alcohol consumption. Another type is adenocarcinoma, which usually occurs in the lower portion of the esophagus.
It begins in the cells of mucus-secreting glands in the esophagus and is caused by chronic acid reflux.

MD Anderson Orlando researchers are at the forefront of Tolfenamic acid research. This same research time had found earlier that Tolfenamic acid limits tumor growth in pancreatic cancer. The researchers are prepared to begin a new Phase I Clinical Trial for pancreatic cancer patients using Tolfenamic acid in a few months.

Although Tolfenamic acid is commonly used as an anti-inflammatory in Europe, Asia and South America, it is still not approved in the United States. The researchers note that further research is needed Tolfenamic acid can be used as a safe and effective drug for esophageal cancer prevention.

اضغط هنا للقراءة باللغة العربية

Prepared by: Abdullatief Janat

Source :


Other Comments

Add a comment

You must sign in to use this servcie


facebook comments

Forgot your password

sign up

Consultants Corner

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Talal Sabouni


Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details